Imperatives of entering China for Ranbaxy

1. Presented By: Abhinav Arya (08EM-002) Abhishek Verma (08EM-004) Ajay Kant Sehgal (08EM-005) Amandeep Singh (08EM-007) Amit Agarwal (08EM-009) Pankaj Gautam (08EM-025)

2. Product Range

9. Recent Acquisitions & Alliances

11. 90’s 80’s Ranbaxy’s Strategy over the years Strategy India       Exports      International   Markets Developing     Emerging       Advanced   Products API, Dosage Form Generics, Branded Generics Competencies Backward integration Developmental research, Regulatory, Manufacturing, Marketing

16. SWOT

18. Porter Diamond Model

21. %age Contribution Direct sale by pharmaceutical manufacturers; 25 State-owned nationwide sales network; and 50 Specialized medication wholesalers and retailers. 25

22. Type Number % Chemical drugs 475 38.2 TCM & Nutraceuticals 324 26.2 Medical equipment & devices 234 18.8 Health care consumables 112 9.0 Biological & chemical agents 67 5.4 Packaging machinery & materials 30 2.4 Total 1242 100

23. Year Total Growth(%) 1980 660.36 1985 971.41 47.1 1990 1605.28 65.3 1992 4796.81 198.8